Announcements Trials

Browse Landscape

Phase

Status

Recruiting 10 Active not recruiting 2 Terminated 1 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Specimen Handling 60 Magnetic Resonance Spectroscopy 41 Carboplatin 32 Gemcitabine 29 Cyclophosphamide 29 Cisplatin 25 Biopsy 25 Bevacizumab 24 pembrolizumab 23 Radiotherapy 22 Paclitaxel 22 Standard of Care 21 Injections 21 Drug Therapy 21 Capecitabine 21 fludarabine 20 Oxaliplatin 20 venetoclax 19 Nivolumab 18 toripalimab 17 Interviews as Topic 17 Dexamethasone 16 Blood Specimen Collection 16 tislelizumab 14 Radiosurgery 14 cemiplimab 13 anlotinib 13 Azacitidine 13 Pemetrexed 12 Irinotecan 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Genetic Testing × 90 days × Clear all

NCT07558343 2026-04-30

MATADOR2

Institut Claudius Regaud

Phase NA Not yet recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡